Literature DB >> 2071901

Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.

C L Karp1, S J Turco, D L Sacks.   

Abstract

Markedly elevated titers of anti-leishmanial antibodies are a hallmark of kala-azar. We investigated the role played by the lipophosphoglycan (LPG) in determining the reactivity of kala-azar serum with the surface of Leishmania donovani promastigotes. In assays performed with liver parasites there was negligible agglutination or fluorescent staining of LPG-bearing promastigotes by kala-azar serum, but strong reactivity in both assays with the use of an L. donovani mutant strain (R2D2) that lacks surface expression of LPG. Immunoprecipitation of lysates of 125I surface-labeled promastigotes indicated that kala-azar serum has reactivity with several surface proteins common to both the wild-type and R2D2 strains, and no reactivity with surface proteins unique to R2D2. Although direct ELISA showed that kala-azar serum recognizes purified promastigote LPG, inhibition ELISA suggested that such recognition is based solely upon reactivity with the normally unexposed core-anchor region of the molecule. We conclude that the poor reactivity of kala-azar serum with the surface of L. donovani promastigotes is caused by its lack of recognition of the exposed phosphodisaccharide repeat units of LPG, which in turn effectively mask the surface molecules that are recognized by kala-azar serum antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2071901

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival.

Authors:  Norikiyo Ueno; Mary E Wilson
Journal:  Trends Parasitol       Date:  2012-06-21

Review 2.  The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes.

Authors:  M J McConville; M A Ferguson
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

3.  Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana.

Authors:  T Ilg
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

4.  Intracellular trafficking of glycosylphosphatidylinositol (GPI)-anchored proteins and free GPIs in Leishmania mexicana.

Authors:  Julie E Ralton; Kylie A Mullin; Malcolm J McConville
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

Review 5.  Secretory pathway of trypanosomatid parasites.

Authors:  Malcolm J McConville; Kylie A Mullin; Steven C Ilgoutz; Rohan D Teasdale
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

6.  Differential Activation of Human Keratinocytes by Leishmania Species Causing Localized or Disseminated Disease.

Authors:  Breanna M Scorza; Mark A Wacker; Kelly Messingham; Peter Kim; Aloysius Klingelhutz; Janet Fairley; Mary E Wilson
Journal:  J Invest Dermatol       Date:  2017-06-22       Impact factor: 8.551

7.  Biosynthesis of the glycolipid anchor of lipophosphoglycan and the structurally related glycoinositolphospholipids from Leishmania major.

Authors:  L Proudfoot; P Schneider; M A Ferguson; M J McConville
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis.

Authors:  A el Harith; S Chowdhury; A al-Masum; S Semião-Santos; E Karim; S el-Safi; I Haque
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

Review 9.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species.

Authors:  M J McConville; L F Schnur; C Jaffe; P Schneider
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.